Hospital value purchasing emerges in China reforms | Deloitte China | Strategy Services has been added to your bookmarks.
Hospital value purchasing emerges in China reforms
How will ongoing health care reform in China shape hospital purchasing behavior?
This is a question that pharma and device companies care about the most, as it directly informs their strategic choices on what to offer and how to serve their customers.
Read the PharmAsia News article to learn Monitor Deloitte's perspective on "Hospital Value Purchasing Emerges In China Reforms" (subscription is needed in order to view the article in full)